Risk factors predicting the outcome of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy. (8th January 2013)

• Record Type: Journal Article
• Authors: Kinoshita, Hidefumi; Shimizu, Yosuke; Mizowaki, Takashi; Takayama, Kenji; Norihisa, Yoshiki; Kamoto, Toshiyuki; Kamba, Tomomi; Hayashino, Yasuaki; Hiraoka, Masahiro; Ogawa, Osamu
• Is Part Of: International journal of urology. Volume 20:Number 8(2013)
• Page Start: 806
• Page End: 811
• Publication Date: 2013-01-08
• Subjects: biochemical progression -- prostate cancer -- prostatectomy -- risk factor -- salvage radiotherapy; Urology -- Periodicals; Genitourinary organs -- Periodicals; Urologic Diseases -- Periodicals; 616.6005
• DOI: 10.1111/iju.12049
• Languages: English
• ISSNs: 0919-8172

Abstract

Abstract : Objectives: Salvage radiotherapy is the only curative treatment for patients with prostate cancer showing biochemical progression after radical prostatectomy. In this study, we evaluated the clinicopathological parameters that influence the outcome of salvage radiotherapy. Methods: Medical records of 49 patients who underwent salvage radiotherapy after radical prostatectomy from 1997 to 2008 at the Graduate School of Medicine, Kyoto University, were retrospectively reviewed. Radiotherapy was carried out with 66 Gy on the prostatic bed. Results: Biochemical progression‐free survival after salvage radiotherapy at 2, 5 and 7 years was 51.0%, 42.2% and 42.2%, respectively. Significant parameters predicting biochemical progression after salvage radiotherapy by Cox regression analysis were prostatectomy Gleason score sum ≥8 (hazard ratio 0.08; 95% confidence interval 0.03–0.22; P = 0.001), prostate‐specific antigen nadir after radical prostatectomy ≥0.04 ng/mL (hazard ratio 0.30; 95% confidence interval 0.13–0.69; P = 0.005) and negative surgical margin (hazard ratio 0.28; 95% confidence interval 0.12–0.70; P = 0.006). When the patients were subgrouped by these risk factors, the 5‐year progression‐free survival rates after salvage radiotherapy were 77.8%, 50.0% and 6.7% in patients with 0, 1 and ≥2 predictors, respectively. Conclusion: In order to discriminate favorable candidates for salvage radiotherapy, Gleason score of prostatectomy, prostate‐specific antigen nadir after prostatectomy and positive surgical margin represent independent predictors. Thus, progression‐free survival might be more precisely predicted according to the presence/absence of these risk factors. The significance of this risk classification should be confirmed by large prospective studies.